Developer docs
API playgroundTry for free, no card

Search company profiles

Twelve Below

Full company profile

uuid0000fis

Namestring
Twelve Below
Legal namestring
Twelve Below, LLC
Websiteurl
twelvebelow.co
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Twelve Below is a New York–based, US-registered venture capital partnership (Twelve Below, LLC) that invests at the pre-seed and seed stages, writing equity checks of $1M to $3M and typically leading rounds. Founded and operated by two partners — Byron Ling (previously partner at Primary and Canaan) and Taylor Greene (previously partner at Lerer Hippeau and Collaborative) — the firm positions itself as a founder's "first true partner," engaging at company inception and providing ongoing strategic, operational, and emotional support across pivots, pricing, hiring, and enterprise GTM. The portfolio of 30+ companies spans six verticals (AI, Energy, Fintech, Healthcare, Hardware, Software) and includes lead investments in Arya Health ($4M seed, Sept 2024) and Barnwell Bio ($6M seed, Jan 2026), plus follow-on participation in Series A rounds for Arya Health, Conduit Health, and Solstice.

The firm generates revenue through standard venture fund economics: management fees on committed capital (regulated under SEC Regulations S-P and S-AM and the Gramm-Leach-Bliley Act per its Privacy Policy) and carried interest on portfolio company exits. Go-to-market is direct-to-founder: outreach via the firm website, hello@twelvebelow.co, LinkedIn, Twitter, and a Medium publication, with no intermediaries or marketplace channels. Pricing is undisclosed in the traditional sense; the "price" of partnership is the $1M–$3M check combined with hands-on partner time and network access.

Customer concentration, AUM, fund-vehicle structures, and LP composition are not disclosed in the source material. Headcount is small (1–10, with two named partners), which structurally limits deployable capital relative to multi-partner firms, and is the primary scaling constraint observed in the data.

Short descriptiontext

Twelve Below is a two-partner, US-based pre-seed and seed venture capital firm writing $1M–$3M checks to lead rounds for ambitious early-stage founders across AI, healthcare, fintech, energy, hardware, and software.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
venture capital investing, seed stage funding, pre-seed investments, early-stage venture capital, lead investor rounds
Industry2 codes
PRIMARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)
SECONDARYFSANAAAB
Early-Stage Venture Capital (Series A/B)
NAICS code1 code
  • Funds, Trusts, and Other Financial Vehicles525
SIC code1 code
  • Investment Advice6282
Product category
Venture Capital
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Venture Capital Fund Management
TypeManaged Services
Description

Twelve Below, LLC operates as a venture capital firm managing funds that invest in early-stage companies. The firm writes $1M–$3M equity checks in pre-seed and seed rounds, generating returns through portfolio company exits (carried interest) and management fees on its funds. The Privacy Policy references the firm being subject to SEC Regulations S-P, S-AM and the Gramm-Leach-Bliley Act, indicating regulated investment adviser activities.

twelvebelow.co
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Others
Pricing details1 tier
1Pre-seed and seed equity investments of $1M to $3M, typically as lead investor
ModelOtherBilling cadenceMulti-year contract
Notes

$1M to $3M checks; lead pre-seed and seed rounds; partner "before the world believes"

twelvebelow.co
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Twelve Below is a venture capital partnership that leads pre-seed and seed funding rounds for early-stage founders, writing equity checks of $1 million to $3 million. The firm positions itself as the founder's "first true partner," pairing capital with hands-on strategic, operational, and emotional support before broader institutional conviction arrives. It typically acts as lead or first institutional investor across AI, Fintech, Healthcare, Energy, Hardware, and Software sectors.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • $1M to $3M check sizes for pre-seed and seed rounds
+1 more record
Product overview1 text field

Twelve Below is a pre-seed and seed venture capital firm, not a SaaS product company. Its single core offering is leading pre-seed and seed rounds with $1M to $3M checks, partnering with founders before institutional investors believe. The "products" extracted below are the portfolio companies in which Twelve Below invests across Fintech, AI, Healthcare, Energy, Hardware, and Software categories — including Arya Health (AI agents for post-acute care admin), Conduit Health (CareOS platform for insurance-covered DME), Health Universe (HIPAA-compliant AI agent infrastructure), Solstice/Sol Health (AI-native pharma marketing), Barnwell Bio (metagenomic livestock biosurveillance), Coral (climate fintech for energy-efficient upgrades), Odyssey Energy Solutions, Accrue, Relay, Mento, Goodwin, Dispatch, Caladan, Aston Labs, Rondah, Indie Health, and others.

Product and service1 record
1Pre-Seed and Seed Venture Capital Investing
CategoryVenture Capital Fund Management
Description

Lead-investor equity funding of $1M to $3M in pre-seed and seed rounds for early-stage startup founders, combined with hands-on partnership support across product, pricing, hiring, and enterprise go-to-market decisions.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

NYC-based pre-seed and seed venture firm; Taylor Greene was previously a Partner at Lerer Hippeau. Directly comparable in stage, check size, and sector breadth, making it the closest structural peer.

TypeDirect peer
Description

NYC-based pre-seed/seed venture firm; Byron Ling was previously a Partner at Primary. Closely comparable in stage focus, founder-first positioning, and multi-sector seed investing.

TypeDirect peer
Description

Seed-stage venture firm with mission-driven, multi-sector mandate; Taylor Greene was previously a Partner at Collaborative. Comparable in stage, check size, and values-oriented seed investing.

TypeDirect peer
Description

Early-stage seed firm focused on pre-seed and seed checks, often first institutional capital; directly comparable stage and founder-first thesis to Twelve Below.

TypeDirect peer
Description

Multi-stage venture firm with deep seed practice; Byron Ling was previously a Partner at Canaan. Comparable in early-stage entry point, though Canaan operates at a meaningfully larger fund size.

TypeDirect peer
Description

NYC-based pre-seed/seed investor focused on AI, consumer, and software infrastructure; comparable stage, geography, and multi-sector pre-seed thesis.

TypeDirect peer
Description

Seed-stage venture firm writing small, concentrated checks in AI and frontier-tech; directly comparable in pre-seed/seed stage and emerging-manager fund size.

TypeBroad incumbent
Description

Global pre-seed investor and startup generator; comparable pre-seed check size and founder-first positioning, but operates at much larger scale and global footprint.

TypeDirect peer
Description

Operator-led seed fund writing $1M-$3M checks as a 'first believer' in pre-seed and seed rounds; directly comparable in stage, check size, and value-add philosophy.

TypeEmerging player
Description

Emerging seed-stage fund focused on early-stage software and consumer; comparable stage and fund size profile to Twelve Below as a newer, smaller seed manager.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment54 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Twelve Below

Venture Capitaltwelvebelow.co

Twelve Below is a two-partner, US-based pre-seed and seed venture capital firm writing $1M–$3M checks to lead rounds for ambitious early-stage founders across AI, healthcare, fintech, energy, hardware, and software.

What Twelve Below does

Twelve Below is a New York–based, US-registered venture capital partnership (Twelve Below, LLC) that invests at the pre-seed and seed stages, writing equity checks of $1M to $3M and typically leading rounds. Founded and operated by two partners — Byron Ling (previously partner at Primary and Canaan) and Taylor Greene (previously partner at Lerer Hippeau and Collaborative) — the firm positions itself as a founder's "first true partner," engaging at company inception and providing ongoing strategic, operational, and emotional support across pivots, pricing, hiring, and enterprise GTM. The portfolio of 30+ companies spans six verticals (AI, Energy, Fintech, Healthcare, Hardware, Software) and includes lead investments in Arya Health ($4M seed, Sept 2024) and Barnwell Bio ($6M seed, Jan 2026), plus follow-on participation in Series A rounds for Arya Health, Conduit Health, and Solstice.

The firm generates revenue through standard venture fund economics: management fees on committed capital (regulated under SEC Regulations S-P and S-AM and the Gramm-Leach-Bliley Act per its Privacy Policy) and carried interest on portfolio company exits. Go-to-market is direct-to-founder: outreach via the firm website, hello@twelvebelow.co, LinkedIn, Twitter, and a Medium publication, with no intermediaries or marketplace channels. Pricing is undisclosed in the traditional sense; the "price" of partnership is the $1M–$3M check combined with hands-on partner time and network access.

Customer concentration, AUM, fund-vehicle structures, and LP composition are not disclosed in the source material. Headcount is small (1–10, with two named partners), which structurally limits deployable capital relative to multi-partner firms, and is the primary scaling constraint observed in the data.

Twelve Below firmographics

Firmographics
Name
Twelve Below
Legal name
Twelve Below, LLC
Website
https://twelvebelow.co
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
1–10 employees
Short description
Twelve Below is a two-partner, US-based pre-seed and seed venture capital firm writing $1M–$3M checks to lead rounds for ambitious early-stage founders across AI, healthcare, fintech, energy, hardware, and software.
Ownership category
akta.pro rank

Twelve Below industry classification

Industry
Product category
Venture Capital
NAICS
Funds, Trusts, and Other Financial Vehicles (525)
SIC
Investment Advice (6282)
akta.pro industry
PRIMARYFSANAAAA
Early-Stage Venture Capital (Pre-Seed/Seed)
SECONDARYFSANAAAB
Early-Stage Venture Capital (Series A/B)

Keywords

  • Venture capital investing
  • Seed stage funding
  • Pre-seed investments
  • Early-stage venture capital
  • Lead investor rounds

Where Twelve Below is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Twelve Below business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Others

Revenue model

  1. Venture Capital Fund Management: Twelve Below, LLC operates as a venture capital firm managing funds that invest in early-stage companies. The firm writes $1M–$3M equity checks in pre-seed and seed rounds, generating returns through portfolio company exits (carried interest) and management fees on its funds. The Privacy Policy references the firm being subject to SEC Regulations S-P, S-AM and the Gramm-Leach-Bliley Act, indicating regulated investment adviser activities.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractPre-seed and seed equity investments of $1M to $3M, typically as lead investor

Go-to-market motion1 record

Distribution channels1 record

Twelve Below product offering

Product offering

Core offering

Twelve Below is a venture capital partnership that leads pre-seed and seed funding rounds for early-stage founders, writing equity checks of $1 million to $3 million. The firm positions itself as the founder's "first true partner," pairing capital with hands-on strategic, operational, and emotional support before broader institutional conviction arrives. It typically acts as lead or first institutional investor across AI, Fintech, Healthcare, Energy, Hardware, and Software sectors.

Product overview

Twelve Below is a pre-seed and seed venture capital firm, not a SaaS product company. Its single core offering is leading pre-seed and seed rounds with $1M to $3M checks, partnering with founders before institutional investors believe. The "products" extracted below are the portfolio companies in which Twelve Below invests across Fintech, AI, Healthcare, Energy, Hardware, and Software categories — including Arya Health (AI agents for post-acute care admin), Conduit Health (CareOS platform for insurance-covered DME), Health Universe (HIPAA-compliant AI agent infrastructure), Solstice/Sol Health (AI-native pharma marketing), Barnwell Bio (metagenomic livestock biosurveillance), Coral (climate fintech for energy-efficient upgrades), Odyssey Energy Solutions, Accrue, Relay, Mento, Goodwin, Dispatch, Caladan, Aston Labs, Rondah, Indie Health, and others.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pre-Seed and Seed Venture Capital Investing Lead-investor equity funding of $1M to $3M in pre-seed and seed rounds for early-stage startup founders, combined with hands-on partnership support across product, pricing, hiring, and enterprise go-to-market decisions.

Quantifiable outcome

  • $1M to $3M check sizes for pre-seed and seed rounds
  • +1 more outcomes

Companies that use Twelve Below

Customer profile

Named customers10 records

Ideal customer profiles1 record

Twelve Below technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Twelve Below partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Twelve Below competitors and assessment

Company assessment

Direct peers

  • Lerer Hippeau: NYC-based pre-seed and seed venture firm; Taylor Greene was previously a Partner at Lerer Hippeau. Directly comparable in stage, check size, and sector breadth, making it the closest structural peer.
  • Primary Venture Partners: NYC-based pre-seed/seed venture firm; Byron Ling was previously a Partner at Primary. Closely comparable in stage focus, founder-first positioning, and multi-sector seed investing.
  • Collaborative Fund: Seed-stage venture firm with mission-driven, multi-sector mandate; Taylor Greene was previously a Partner at Collaborative. Comparable in stage, check size, and values-oriented seed investing.
  • Precursor Ventures: Early-stage seed firm focused on pre-seed and seed checks, often first institutional capital; directly comparable stage and founder-first thesis to Twelve Below.
  • Canaan Partners: Multi-stage venture firm with deep seed practice; Byron Ling was previously a Partner at Canaan. Comparable in early-stage entry point, though Canaan operates at a meaningfully larger fund size.
  • Betaworks: NYC-based pre-seed/seed investor focused on AI, consumer, and software infrastructure; comparable stage, geography, and multi-sector pre-seed thesis.
  • Vine Ventures: Seed-stage venture firm writing small, concentrated checks in AI and frontier-tech; directly comparable in pre-seed/seed stage and emerging-manager fund size.
  • Everywhere VC: Operator-led seed fund writing $1M-$3M checks as a 'first believer' in pre-seed and seed rounds; directly comparable in stage, check size, and value-add philosophy.

Broad incumbents

  • Antler: Global pre-seed investor and startup generator; comparable pre-seed check size and founder-first positioning, but operates at much larger scale and global footprint.

Emerging players

  • Carya Venture Partners: Emerging seed-stage fund focused on early-stage software and consumer; comparable stage and fund size profile to Twelve Below as a newer, smaller seed manager.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Twelve Below social profiles

Digital presence

Twelve Below financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Twelve Below leadership team

Management profile

Number of profiles

Profiles2 records

Twelve Below subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Twelve Below funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Twelve Below M&A and investment

M&A and investment

M&A

Investments54 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Twelve Below

What does Twelve Below do?

Twelve Below is a venture capital partnership that leads pre-seed and seed funding rounds for early-stage founders, writing equity checks of $1 million to $3 million. The firm positions itself as the founder's "first true partner," pairing capital with hands-on strategic, operational, and emotional support before broader institutional conviction arrives. It typically acts as lead or first institutional investor across AI, Fintech, Healthcare, Energy, Hardware, and Software sectors.

Is Twelve Below a public or private company?

Twelve Below is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Twelve Below founded?

Twelve Below was founded in 2021. It employs 1 to 10 people.

Where is Twelve Below based?

Twelve Below is headquartered in New York, United States, in the North America region.

How does Twelve Below make money?

One revenue line is on record: venture Capital Fund Management.

Who are Twelve Below's main competitors?

Direct peers on record are Lerer Hippeau, Primary Venture Partners, Collaborative Fund, Precursor Ventures, Canaan Partners, Betaworks, Vine Ventures and Everywhere VC. Antler is listed as a broad incumbent. Carya Venture Partners is listed as an emerging player.

Does Twelve Below have an API?

No public API is recorded for Twelve Below.

What industry is Twelve Below in?

Twelve Below's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAA, Early-Stage Venture Capital (Pre-Seed/Seed), with a secondary code of FSANAAAB, Early-Stage Venture Capital (Series A/B). Its NAICS code is 525 and its SIC code is 6282.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Venture Capital Access OnlineOdyssey Energy Solutions Raises $74 Million to Accelerate Distributed Renewable Energy Financing in Emerging MarketsOdyssey Energy Solutions raised $74 million in new financing, including $27 million equity and $47 million debt, to expand its distributed renewable energy platform. The platform connects over 6,000 installers and EPCs across 50+ countries, facilitating access to $3.6 billion in capital. The funding will support procurement platform expansion and project deployment.Venture Capital Access OnlineBoard Raises $20 Million Series A led by Union Square Ventures to Build the Future of Face-to-Face Gaming and CreationBoard raised $20 million in a Series A led by Union Square Ventures to expand from a gaming console to a creator platform. The company will launch Board Studio later this year, enabling natural-language game creation. The platform is open to builders, with the first community-built game launching in July.FinSMEsBoard Raises $20M in Series A FundingBoard, a tabletop game console developer, raised $20M in Series A funding led by Union Square Ventures. The company will use the funds to expand from hardware to an open creator ecosystem and launch its Board Studio software. It has deployed its console across tens of thousands of homes, schools, and hospitals.VC News DailySolstice Secures $21M Series A FinancingSolstice, an AI-native marketing agency for pharma, raised $21 million in Series A funding led by Transformation Capital, with participation from Twelve Below, Virtue Ventures, and others. The round brings total funding to approximately $25 million, which will fuel go-to-market expansion, product development, and team growth.Pulse 2.0Solstice: $21 Million Series A Raised To Accelerate Pharma CommercializationSolstice, an AI-native marketing agency focused on accelerating pharmaceutical commercialization, announced it raised $21 million in Series A funding led by Transformation Capital, with participation from Twelve Below, Virtue Ventures, and others, bringing total funding to approximately $25 million. The capital will support go-to-market expansion, product development, and team growth across product and customer-facing functions. The company claims customers can launch marketing campaigns 12 times faster than traditional agencies, with content moving from concept to market-ready in roughly 10 days, and now serves more than a dozen pharmaceutical companies including several top 20 pharma brands.HIT ConsultantSolstice Secures $21M for AI-Native Pharmaceutical Marketing PlatformSolstice, an AI-native pharmaceutical marketing platform, announced a $21M Series A funding round led by Transformation Capital, with participation from Twelve Below and Virtue Ventures, bringing total funding to approximately $25M. The platform compresses traditional pharmaceutical marketing asset delivery cycles from three months to 10 days by pairing generative AI algorithms with in-house medical experts, reducing average MLR review cycles from 3.2 rounds to 1.2 rounds per asset and enabling 12x faster campaign launches. The company now serves over a dozen pharmaceutical organizations, including multiple top-20 global pharma brands across oncology, immunology, and metabolic diseases.Venture Capital Access OnlineSolstice Raises Series A to Radically Accelerate Pharma CommercializationSolstice raised $21 million in Series A funding led by Transformation Capital, bringing total funding to about $25 million. The capital will fund go-to-market expansion and product development. The company's AI platform cuts medical, legal, and regulatory review cycles from weeks to under 48 hours.VentureburnSolstice Secures $21M Series A for Pharma InnovationSolstice raised $21 million in a Series A led by Transformation Capital, bringing total funding to roughly $25 million. The AI-native marketing platform claims to cut multi-month MLR review cycles to under 48 hours, and will use the capital for go-to-market expansion and product engineering.FinSMEsSolstice Raises $21M in Series A FundingSolstice, an AI-native marketing agency for pharma, raised $21M in Series A funding led by Transformation Capital. The round brings total funding to about $25M, which the company will use to accelerate go-to-market expansion, product development, and team growth.RondahAI Receptionist for Dental Support OrganizationsRondah AI has raised a $3.5 million pre-seed round co-led by Twelve Below and 2048 Ventures to scale its AI-powered receptionist platform for dental practices and Dental Support Organizations (DSOs). The company deploys AI agents that handle patient calls, appointment scheduling, follow-ups, and office workflows 24/7, reportedly eliminating missed calls and doubling appointment bookings for practices using the system. The funding will be used to expand into outbound recalls, insurance workflows, multi-language support, and integration with existing dental technology stacks.